Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

City of Hope Medical Center · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
autologous hematopoietic stem cell transplant recipient, loss of chromosome 17p, plasma cell leukemia, recurrent plasma cell myeloma, refractory plasma cell myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834984
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.